Abstract
Background Diabetes Mellitus Type 2 (T2DM) is a global health problem that continues to increase. Suboptimal treatment can worsen the patient’s condition, cause more serious complications, and increase the death rate. The role of various health professionals in the management of T2DM in the community is increasingly recognized as an important element for achieving better outcomes. Objective of this review is to identify and analyze the role of each health professional and their challenges in treating T2DM.
Method Review of the scope of the main research that discusses it the role of the role of each health professional health professional in treating T2DM in the community. Various databases were searched via Web of Science, Scopus, PubMed, and ProQuest. Four databases were searched and 462 articles were retrieved. After screening articles and abstracts, 51 full texts were assessed for eligibility, and finally 9 studies were further analyzed and synthesized.
Results seven quantitative studies and two qualitative studies met the inclusion criteria. Four themes emerged: (1) the role of each health professional, (2) Determining factors for the success of T2DM treatment, (3) Challenges in treating T2DM, and (4) Health policy and support systems.
Conclusion found unclear role definitions for healthcare professionals managing T2DM, leading to overlapping responsibilities and inefficiencies in patient care. This study highlights the importance of a clear and standardized treatment protocol and guideline, containing clear roles for each health professional for the management of people with T2DM in the community. Governments need to promote IPC and provide the necessary resources and infrastructure to support collaborative practice resulting in better outcomes for T2DM patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos